Anthocyanins inhibit trastuzumab-resistant breast cancer in vitro and in vivo

Molecular Medicine Reports

Volumn 13, Issue 5, 2016, Pages 4007-4013

  Li, Xin ^a   Xu, Jinmei ^b   Tang, Xi ^b   Liu, Yilun ^b   Yu, Xiaoping ^a   Wang, Zhi ^b   Liu, Weihua ^b  

^a CHENGDU MEDICAL COLLEGE   (China)

^b FIRST AFFILIATED HOSPITAL   (China)

Author keywords

Anthocyanins; Cyanidin 3 glucoside; Drug resistant; Peonidin 3 glucoside

Indexed keywords

ANTHOCYANIN; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; CYANIDIN 3 GLUCOSIDE; PEONIDIN 3 GLUCOSIDE; TRASTUZUMAB; UNCLASSIFIED DRUG; CYANIDIN 3-O-GLUCOSIDE; GLUCOSIDE; PEONIDIN 3-GLUCOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASIA; BREAST CANCER; CANCER INHIBITION; CANCER RESISTANCE; CANCER THERAPY; CELL INVASION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; STAINING; TUMOR INVASION; WESTERN BLOTTING; ANIMAL; BREAST NEOPLASMS; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; METABOLISM; NUDE MOUSE; PATHOLOGY;

ANIMALS; ANTHOCYANINS; APOPTOSIS; BREAST NEOPLASMS; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUCOSIDES; HUMANS; MICE; MICE, NUDE; TRASTUZUMAB; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84964792522     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2016.4990     Document Type: Article

References (19)

1. American Cancer Society: Cancer Facts & Figures 2015. American Cancer Society, Atlanta, GA, 2015.
2. Lv F, Yu Y, Zhang B, Liang D, Li ZM and You W: Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER (+/-) breast cancer cells and action mechanisms. J Huazhong Univ Sci Technolog Med Sci 33:870-876, 2013.
3. Bedard PL, Cardoso F and Piccart-Gebhart MJ: Stemming resistance to HER-2 targeted therapy. J Mammary Gland Biol Neoplasia 14:55-66, 2009.
4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A and McGuire WL: Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182, 1987.
5. Hynes NE and Lane HA: ERBB receptors and cancer: The complexity of targeted inhibitors. Nat Rev Cancer 5:341-354, 2005.
6. Vrbic S, Pejcic I, Filipovic S, Kocic B and Vrbic M: Current and future anti-HER2 therapy in breast cancer. J BUON 18:4-16, 2013.
7. Liu W, Xu J, Wu S, Liu Y, Yu X, Chen J, Tang X, Wang Z, Zhu X and Li X: Selective anti-proliferation of HER2-positive breast cancer cells by anthocyanins identified by high-throughput screening. PLoS One 8:e81586, 2013.
8. Liu W, Xu J, Liu Y, Yu X, Tang X, Wang Z and Li X: Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2-positive breast cancer cells in vitro and in vivo. Mol Med Rep 10:1921-1926, 2014.
9. Nahta R, Takahashi T, Ueno NT, Hung MC and Esteva FJ: P27 (kip1) down-regulation is associated with trastuzumab resistance in breast cancer cells. Cancer Res 64:3981-3986, 2004.
10. Nahta R and Esteva FJ: In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells. Cancer Chemother Pharmacol 53:186-190, 2004.
11. Chen PN, Chu SC, Chiou HL, Chiang CL, Yang SF and Hsieh YS: Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo. Nutr Cancer 53:232-243, 2005.
12. Chen PN, Chu SC, Chiou HL, Kuo WH, Chiang CL and Hsieh YS: Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line. Cancer Lett 235:248-259, 2006.
13. Ding M, Feng R, Wang SY, Bowman L, Lu Y, Qian Y, Castranova V, Jiang BH and Shi X: Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J Biol Chem 281:17359-17368, 2006.
14. Cooke D, Schwarz M, Boocock D, Winterhalter P, Steward WP, Gescher AJ and Marczylo TH: Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis - relationship with tissue anthocyanin levels. Int J Cancer 119:2213-2220, 2006.
15. Fernandes I, Marques F, de Freitas V and Mateus N: Antioxidant and antiproliferative properties of methylated metabolites of anthocyanins. Food Chem 141:2923-2933, 2013.
16. Kamenickova A, Anzenbacherova E, Pavek P, Soshilov AA, Denison MS, Zapletalova M, Anzenbacher P and Dvorak Z: Effects of anthocyanins on the AhR-CYP1A1 signaling pathway in human hepatocytes and human cancer cell lines. Toxicol Lett 221:1-8, 2013.
17. Chen XQ, Nagao N, Itani T and Irifune K: Anti-oxidative analysis and identification, and quantification of anthocyanin pigments in different coloured rice. Food Chem 135:2783-2788, 2012.
18. Fernandes I, Faria A, Azevedo J, Soares S, Calhau C, De Freitas V and Mateus N: Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type phenolics on breast cancer cell proliferation. J Agric Food Chem 58:3785-3792, 2010.
19. Heinonen M: Antioxidant activity and antimicrobial effect of berry phenolics - a Finnish perspective. Mol Nutr Food Res 51:684-691, 2007.